Trial intelligence / Profile preview

Intrauterine human chorionic gonadotropin (HCG) and outcome of embryo transfer cycles

IRCT20200213046475N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of human chorionic gonadotropin in primary infertility, sponsored by Tehran University of Medical Sciences. Started Mar 2020; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

primary infertility

Beyond the preview

Go deeper on IRCT20200213046475N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200213046475N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call